Psilocybin, the active compound in hallucinogenic mushrooms, is edging into mainstream psychiatry in parts of Europe – with Switzerland already treating patients and the Czech Republic opening tightly ...

Unbound Medicine and Johns Hopkins Medicine today announced a significant expansion of the Johns Hopkins Psychiatry POC-IT Guide, a leading digital resource for clinicians and trainees worldwide. The ...

Believers in the healing potential of the mind-altering drugs thought RFK Jr. was the answer to their prayers. They’re still waiting.

WEST PALM BEACH, Fla. (CBS12) — If you are someone who suffers from common mental health conditions, new research involving the use of psychedelics could be the key to treating an array of disorders ...

Psychedelic therapy isn’t just about the drug; it’s about the dose, too. Here's why the overlooked middle ground may matter ...

From magic mushrooms to peyote, psychedelics have made a name for themselves in recent years as potential therapeutics for a range of different conditions, including post-traumatic stress disorder, ...

The future of psychedelic research was dealt its biggest setback in years after the FDA declined to approve midomafetamine (MDMA) capsules for post-traumatic stress disorder (PTSD) earlier this month, ...

A new review criticizes current methods of measuring the acute subjective effects of psychedelics. Experts call for the development of new, more comprehensive measures that can accurately assess ...

Healing Hearts, Changing Minds (HHCM) today announced the seven awardees of Walking Each Other Home: A Fund to Promote Psychedelic Compassion for End-of-Life Care, a $566,260 philanthropic initiative ...

Every day in America, we lose on average from 17 to 44 veterans to suicide — more than the average daily casualties during active military conflicts in Vietnam, Iraq and Afghanistan combined. As a ...

Researchers used EEG to study high-dose inhaled 5-MeO-DMT in humans. Unlike other psychedelics, the drug reduced brain ...